Novo Integrated Sciences Profit Margin 2012-2024 | NVOS
Current and historical gross margin, operating margin and net profit margin for Novo Integrated Sciences (NVOS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Novo Integrated Sciences net profit margin as of August 31, 2024 is 0%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $21.079B | 19.62 |
| Elanco Animal Health (ELAN) | United States | $12.188B | 25.55 |
| Encompass Health (EHC) | United States | $10.112B | 19.44 |
| DaVita (DVA) | United States | $7.395B | 10.80 |
| Chemed (CHE) | United States | $6.401B | 22.48 |
| Option Care Health (OPCH) | United States | $5.719B | 24.34 |
| RadNet (RDNT) | United States | $5.477B | 186.82 |
| LifeStance Health (LFST) | United States | $2.820B | 0.00 |
| Addus HomeCare (ADUS) | United States | $1.987B | 20.52 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.926B | 24.26 |
| Astrana Health (ASTH) | United States | $1.517B | 141.84 |
| U.S Physical Therapy (USPH) | United States | $1.308B | 33.08 |
| Pennant (PNTG) | United States | $1.008B | 33.51 |
| Daxor (DXR) | United States | $0.066B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.050B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |